The phenomenon of endotoxin sensitization by virus infection is well documented but not yet well understood. Infection by virtually any viral agent will quickly induce expression of type I interferons (IFN-α/β), and type II IFN-γ production will follow as NK cells and T cells are activated. It has been well established that type II IFN pretreatment can intensify the effects of endotoxin. We have recently demonstrated that type I IFN induction by lymphocytic choriomeningitis virus (LCMV) infection dramatically increases TNF-α production following LPS treatment, and that this sensitization by type I IFN is STAT1 dependent. Taken together these data suggest that the STAT1-mediated, MyD88-independent, arm of the LPS signaling pathway plays an important role in endotoxin toxicity, and that this pathway mediates a major component of virus-enhanced LPS sensitization.
References
1.
Biron CAInterferons alpha and beta as immune regulators — a new look. Immunity2001; 14: 661—664.
2.
Levy D., Garcia-Sastre A.The virus battlers: IFN induction of the antiviral state and mechanisms of viral evasion. Cytokine Growth Factor Rev2001; 12: 143—156.
3.
Malmgaard L. , Salazar-Mather T-P., Lewis CA, Biron CAPromotion of alphabeta interferon induction during in vivo viral infection through alpha/beta interferon receptor/STAT1 system-dependent and -independent pathways. J Virol2002; 76: 4520—4525.
4.
Biron CA, Nguyen KB, Pien GCInnate immune responses to LCMV infections: natural killer cells and cytokines . Curr Top Microbiol Immunol2002; 263: 7—27.
5.
Nguyen KB, Biron CASynergism for cytokine mediated disease during concurrent endotoxin and viral challenges: roles for NK and T cell IFN-gamma production. J Immunol1999; 162: 5238—5246.
6.
Dinarello CACytokines as mediators in the pathogenesis of septic shock. Curr Top Microbiol Immunol1996 ; 216: 133—165.
7.
Beutler B., Milsark IW, Cerami ACPassive immunization against cachectin/tumor necrosis factor protects mice from lethal effects of endotoxin. Science1985; 229: 869—871.
8.
Pfeffer K., Matsuyama T., Kundig TM et al. Mice deficient for the 55 kDa tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection . Cell1993; 73: 457—467.
9.
Car BD, Eng VM, Schnyder B. et al. Interferon-gamma receptor deficient mice are resistant to endotoxic shock. J Exp Med1994; 179: 1437—1444.
10.
Billau A., Heremans H., Vandekerckhove F., Dillen C.Anti-interferon-γ antibody protects mice against the generalized Shwartzman reaction. Eur J Immunol1987; 17: 1851—1854.
11.
Degre M., Glasgow LASynergistic effect in viral-bacterial infection. I. Combined infection of the respiratory tract in mice with parainfluenza virus and Hemophilus influenza . J Infect Dis1968; 118: 449—462.
12.
Leung WC, Hashimoto K.Modification of susceptibility to Klebsiella pneumoniae during murine cytomegalovirus infection. Microbiol Immunol1986; 30: 761—776.
13.
Durbin J., Hackenmiller R., Simon M., Levy D.Targeted disruption of the STAT1 gene results in compromised innate immunity to viral disease. Cell1996; 84: 443—450.
14.
Muller U., Steinhoff U., Reis Lfl et al. Functional role of type I and type II interferons in antiviral defense. Science1994; 264: 1918—1921.
15.
Mombaerts P. , Iacomini J., Johnson RS et al. RAG-1 deficient mice have no mature B and T lymphocytes. Cell1992; 68: 869—877.
16.
Wang B., Biron C., She J. et al. A block in both early T lymphocyte and natural killer cell development in transgenic mice with high copy numbers of the human CD3ε gene. Proc Natl Acad Sci USA1994; 91: 9402—9406.
17.
Dalton DK, Pitts-Meek S., Keshav S. et al. Multiple defects of immune cell function in mice with disrupted interferon-gamma genes. Science1993; 259: 1693—1694.
18.
Doughty LA, Nguyen KB, Durbin JE, Biron CAA role for interferon-alpha/beta in virus infection-induced sensitization to endotoxin. J Immunol2001; 166: 2658—2664.
19.
Stark GR, Kerr IM, Williams Brg et al. How cells respond to interferons. Annu Rev Biochem1998; 67: 227—264.
20.
Toshchakov V., Jones BW, Perera P-Y. et al. TLR4, but not TLR2, mediates IFN-beta-induced STATlalpha/beta-dependentgene expression in macrophages. Nat Immunol2002; 3: 1—7.
21.
Kawai T., Takeuchi O., Fujita T. et al. Lipopolysaccharide stimulates the MyD88-independent pathway and results in activation of IFN-regulatory factor 3 and the expression of a subset of lipopolysaccharide-induced genes. J Immunol2001; 167: 5887—5894.
22.
Ohmori Y., Hamilton TARequirement for STAT1 in LPSinduced gene expression in macrophages. J Leukoc Biol2000; 69: 598—604.
23.
Poltorak A. , He X., Smirnova I. et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science1998; 282: 2085—2088.
24.
Marie I., Durbin J., Levy D.Differential viral induction of distinct interferon-alpha genes by positive feedback through interferon regulatory factor-7. EMBO J1998; 17: 6660—6669.
25.
Servant MJ, ten Oever B., LePage C. et al. Identification of distinct signaling pathways leading to the phosphorylation of interferon regulatory factor 3. J Biol Chem2001; 276: 355—363.
26.
Levy DE, Garcia-Sastre A.The virus battles: IFN induction of the antiviral state and mechanisms of viral evasion. Cytokine Growth Factor Rev2001; 12: 143—156.
27.
Reich NCNuclear/cytoplasmic localization of IRFs in response to viral infection of interferon stimulation. J Interferon Cytokine Res2002; 22: 103—109.
